Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR
Hengyu Lu, Huai‐Xiang Hao(Novartis (Switzerland))
Cited by 41
Related Papers
Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling
|Clinical Cancer Research|2020|161